SCI Abstract

search
+
[Correspondence] Management of gastrointestinal services in Tamil Nadu, India, during COVID-19
In India, during the first wave of the COVID-19 pandemic, the state of Tamil Nadu become a COVID-19 hotspot between April ...
[Review] Diabetes following acute pancreatitis
1.Hart PA Bellin MD Andersen DK et al.Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pan...
[Comment] The changing prevalence of functional constipation: why words matter
Even when uniform symptom-based criteria are used to define the presence of functional constipation, prevalence varies bet...
[Articles] Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis
1.Ford AC Moayyedi P Lacy BE et al.American college of gastroenterology monograph on the management of irritable bowel syn...
[Review] Transmural healing as a therapeutic goal in Crohn's disease: a systematic review
1.Torres J Mehandru S Colombel J-F Peyrin-Biroulet L Crohn's disease.Lancet. 389: 1741-17552.Torres J Bonovas S Doherty G ...
[Clinical Picture] Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination
A 41-year-old man with an unremarkable medical history presented to the emergency department with a headache that woke him...
[News] Urgent action needed to eliminate viral hepatitis by 2030
WHO's global health sector strategy on viral hepatitis 2016–21 was designed to eliminate viral hepatitis as a major public...
[Comment] Complexity of paediatric trials restricts effect on clinical practice
Inflammatory bowel disease (IBD) has become a major burden of health care, with the number of adult and paediatric p...
[Articles] Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study
Background Biologic treatment options are limited for children with ulcerative colitis. The aim of t...
[Articles] Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study
Department of Infectious Diseases, Landspitali - The National University Hospital of Iceland, Reykjavik, IcelandDepartment...
[Comment] Hepatitis C in Iceland: a milestone for global elimination
In The Lancet Gastroenterology & Hepatology, Sigurdur Olafsson and colleagues report that important WHO service covera...
[News] 6th World Congress of Paediatric Gastroenterology, Hepatology and Nutrition
Cyclic exclusive enteral nutrition could be used to maintain remission in children and adolescents with Crohn's dise...
[In Focus] In the light of evolution
“Nothing in biology makes sense except in the light of evolution”, wrote the oft-quoted evolutionary biologist Theod...
[Comment] Mentorship and women in gastroenterology
Mentorship is crucial to a successful career in medicine, particularly for physicians seeking to succeed in an acade...
[Comment] Diversity in clinical trials: an opportunity and imperative for community engagement
Enhancing clinical trial diversity is a moral and scientific imperative. The lack of diversity is an obstacle to understan...
[Correspondence] Pooling samples for hepatitis C RNA detection
Servicio de Microbiología, Complexo Hospitalario Universitario de Santiago, Santiago de Compostela, SpainDepartamento de M...
[Correspondence] Double trouble: a pandemic of obesity and COVID-19
The Lancet Gastroenterology & Hepatology's editorial, Obesity: another ongoing pandemic,1The Lancet Gastroenterology &...
[Editorial] Alcohol-related harms and the case for minimum unit pricing
3 years after Scotland became the first country in the world to introduce minimum unit pricing for alcohol, a new analysis...
[News] Digestive Disease Week 2021
Bruce Sands (New York City, NY, USA) presented data from the SEAVUE trial—the first head-to-head comparison of biolo...
[Comment] Treatment-as-prevention in prison settings: a growing evidence base for HCV elimination efforts
Progress towards the elimination of hepatitis C virus (HCV) is underway globally, with some countries such as Austra...
[Comment] Therapeutic targeting of VEGFR2 in HBV-associated hepatocellular carcinoma
Department of Surgery and Cancer, Imperial College London, Faculty of Medicine, London W12 0HS, UKDivision of Molecular Pa...
[Articles] Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Hepatitis B virus (HBV) infection is the leading global cause of hepatocellular carcinoma, with over 350 million people be...
[Review] Breaking the therapeutic ceiling in drug development in ulcerative colitis
1.Ulcerative colitis.Nat Rev Dis Primers. 6: 732.Harbord M Eliakim R Bettenworth D et al.Third European evidence-based con...
[Comment] Defining difficult-to-treat inflammatory bowel disease: why and how
Major progress has been made in the diagnosis, drug development, and treatment of Crohn's disease and ulcerative col...
[Correspondence] SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?
Since the publication of the British Society of Gastroenterology (BSG) Inflammatory Bowel Disease (IBD) section position s...
[Comment] Towards meaningful change: the future of gastroenterology belongs to women, diversity, equity, and inclusion
When reflecting on 2020, the term unprecedented is the resounding descriptor for not only the events that occurred, ...
[Correspondence] SARS-CoV-2 vaccination for patients with inflammatory bowel disease
We read with interest the position statement of the British Society of Gastroenterology Inflammatory Bowel Disease (IBD) s...
[Correspondence] SARS-CoV-2 vaccination for patients with inflammatory bowel disease – Authors' reply
We thank Garcia Garrido and colleagues for their comments on the British Society of Gastroenterology Inflammatory Bowel Di...
[Correspondence] Anal cancer screening in low-income and middle-income countries
South American Program in HIV Prevention Research, University of California Los Angeles, Los Angeles, CA 90095, USAProgram...
[News] USPSTF: colorectal cancer screening in the US from 45 years
On May 18, 2021, the US Preventive Services Task Force (USPSTF) updated its guidance for colorectal cancer screening...
Load More
format_indent_increase